HHS Formalizes 340B Policy As Court Fight Continues
The U.S. Department of Health and Human Services on Monday released a new regulation requiring drugmakers to discount so-called orphan drugs when hospitals use them for conditions that aren't rare, hoping...To view the full article, register now.
Already a subscriber? Click here to view full article